← Back to Search

Vaccine Norms Feedback for Vaccine Hesitancy

N/A

Recruiting

Led By Scott Graupensperger, PhD

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 6 months

Awards & highlights

Study Summary

This trial will use an online intervention to correct misperceived social norms related to vaccine hesitancy among young adults (18-25) in order to increase uptake & reduce time to first dose of the COVID-19 vaccine.

Who is the study for?

This trial is for young adults aged 18-24 in the US who haven't had a COVID-19 vaccine and are willing to participate. They must understand English well, pass attention checks during screening, and give their consent to be part of the study.Check my eligibility

What is being tested?

The study tests an online intervention giving personalized feedback based on social norms to reduce vaccine hesitancy among young adults. Participants will be randomly assigned to receive this intervention or an attention-matched control, with follow-ups over six months.See study design

What are the potential side effects?

Since this trial involves no medical treatments but rather informational feedback, there are no direct physical side effects expected from participating in the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

COVID-19 vaccine attitudes

COVID-19 vaccine uptake

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Vaccine Norms FeedbackExperimental Treatment1 Intervention

The participants in the treatment condition will receive personalized normative feedback (PNF) that entails correcting normative misperceptions for US young adults' vaccine uptake rates and prevalence of vaccine hesitancies (e.g., fear of side effects). Participants will be shown discrepancies between their perceived estimate of young adults' vaccination rates and actual national estimates derived from the US Census Bureau's Household Pulse Survey to highlight, in most cases, that they underestimated the vaccination norms.

Group II: Alcohol Norms FeedbackActive Control1 Intervention

Participants randomized to control will complete all measures at the same time as participants in the treatment condition, but will not receive any normative information regarding vaccines. Instead, to match for attention and provide potential benefit, those in the control condition will receive a standard dynamic norms feedback pertaining to alcohol use norms and behaviors.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor

1,740 Previous Clinical Trials

1,847,070 Total Patients Enrolled

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,476,802 Total Patients Enrolled

Scott Graupensperger, PhDPrincipal InvestigatorUniversity of Washington

Media Library

Alcohol Norms Feedback Clinical Trial Eligibility Overview. Trial Name: NCT05787015 — N/A

Coronavirus Research Study Groups: Vaccine Norms Feedback, Alcohol Norms Feedback

Coronavirus Clinical Trial 2023: Alcohol Norms Feedback Highlights & Side Effects. Trial Name: NCT05787015 — N/A

Alcohol Norms Feedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT05787015 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment number for this research project?

"Affirmative, the information available on clinicaltrials.gov indicates that recruitment is still ongoing for this trial which was originally posted in October of 2022 and updated last March. The study seeks to enroll 600 participants across one location."

Answered by AI

Can persons younger than fifty years participate in this research?

"The age restriction for enrolment in this clinical trial is between 18 and 24 years old. For comparison, there are 119 trials specifically designed for patients aged under 18, and 738 catering to individuals over 65."

Answered by AI

Are there any desirable characteristics for potential participants of this experiment?

"Entry into this research endeavour necessitates coronavirus infection and a age range of between 18-24. Altogether, 600 individuals are being sought for the trial."

Answered by AI

Are there still opportunities for individuals to participate in this research?

"Affirmative. Data available on clinicaltrials.gov shows that this medical study, which first appeared online on the 6th of October 2022, is actively looking for participants. 600 individuals are required to participate across a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy

Scott Graupensperger 2022. "Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05787015.